Over the past twenty years, the U.S. government has carried out an enormous and largely unknown global campaign to protect pharmaceutical companies. This has included extensive efforts to pressure our trading partners to raise prices for pharmaceutical drugs. Often, U.S. trade officials ask countries to adopt policies that are contrary to U.S. domestic law, and that far exceed obligations under U.S. trade agreements. These policies present ethical dilemmas, as the world faces a crisis in access to essential medicines.
Learning Objectives: At the end of the presentation, the participant will recognize the impact of U.S. trade policies on access to medicines and the ethical dilemma that these present
Keywords: Drugs, Access
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.
The 128th Annual Meeting of APHA